Feedworks USA Ltd. – Trademark Portfolio

Entity Type: 16

Feedworks USA Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 3 are pending. Notable registered marks include ETX-5, MAKE A SPLASH, and FEEDWORKS LYTES. The owner is based in Cincinnati, OH.

2407 Ashland Avenue

Cincinnati, OH 45206

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Feedworks USA Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Feedworks USA Ltd. have?

Feedworks USA Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 pending.

What trademark classes does Feedworks USA Ltd. file in?

Feedworks USA Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Feedworks USA Ltd.'s most well-known trademarks?

Feedworks USA Ltd.'s registered trademark portfolio includes well-known marks such as ETX-5, MAKE A SPLASH, and FEEDWORKS LYTES. These are among 3 currently registered trademarks in the portfolio.

What is Feedworks USA Ltd.'s trademark registration success rate?

Feedworks USA Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 3 applications are pending review.